Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

False-positive results in a population-based colorectal screening programme: cumulative risk from 2000 to 2017 with biennial screening.

Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: cebp.1368.2018. doi: 10.1158/1055-9965.EPI-18-1368. [Epub ahead of print]

PMID:
31488415
2.

Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.

Benito L, Travier N, Binefa G, Vidal C, Espinosa J, Milà N, Garcia M.

Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.

PMID:
30890542
3.

Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.

Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C, Espinosa J, Moreno V, Garcia M.

Prev Med. 2019 Feb;119:58-62. doi: 10.1016/j.ypmed.2018.12.013. Epub 2018 Dec 28.

PMID:
30594532
4.

Cross-sectional survey on awareness of colorectal cancer and a screening programme for primary health care professionals in Catalonia, Spain.

Benito L, García M, Binefa G, Mila N, Vidal C, Lluch MT, Puig M; Primary Care-Screening Working Group.

Eur J Cancer Care (Engl). 2016 Nov;25(6):992-1004. doi: 10.1111/ecc.12450. Epub 2016 Feb 16.

PMID:
26880138
5.

Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.

Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A.

Endoscopy. 2016 Nov;48(11):995-1002. Epub 2016 Aug 2.

PMID:
27485482
6.

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V.

Eur J Cancer Prev. 2017 Sep;26(5):365-367. doi: 10.1097/CEJ.0000000000000281.

PMID:
27433880
7.

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V.

Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532.

8.

[Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].

Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V.

Gac Sanit. 2015 Nov-Dec;29(6):464-71. doi: 10.1016/j.gaceta.2015.07.002. Epub 2015 Sep 2. Review. Spanish.

9.

Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.

Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V.

Gastroenterol Res Pract. 2015;2015:672410. doi: 10.1155/2015/672410. Epub 2015 Feb 24.

10.

Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?

Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V.

Eur J Cancer Prev. 2015 Jul;24(4):321-7. doi: 10.1097/CEJ.0000000000000090.

PMID:
25370684
11.

Defining the role of the nurse in population-based cancer screening programs.

Benito L, Binefa G, Lluch T, Vidal C, Milà N, Puig M, Roldán J, Garcia M.

Clin J Oncol Nurs. 2014 Aug;18(4):E77-83. doi: 10.1188/14.CJON.E77-E83. Review.

PMID:
25095308
12.

Use of text-message reminders to improve participation in a population-based breast cancer screening program.

Vidal C, Garcia M, Benito L, Milà N, Binefa G, Moreno V.

J Med Syst. 2014 Sep;38(9):118. doi: 10.1007/s10916-014-0118-x. Epub 2014 Jul 30.

PMID:
25073694
13.

Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.

Binefa G, García M, Milà N, Rodríguez L, Rodríguez-Moranta F, Guardiola J, Moreno V.

Rev Esp Enferm Dig. 2013 Aug;105(7):400-8.

14.

False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

Garcia M, Milà N, Binefa G, Borràs JM, Espinàs JA, Moreno V.

J Med Screen. 2012 Jun;19(2):77-82. doi: 10.1258/jms.2012.012013. Epub 2012 May 31.

PMID:
22653571
15.

[Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008].

Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V.

Gac Sanit. 2012 May-Jun;26(3):217-22. doi: 10.1016/j.gaceta.2011.10.020. Epub 2012 Feb 22. Spanish.

16.

Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.

Garcia M, Borràs JM, Binefa G, Milà N, Espinàs JA, Moreno V.

Eur J Cancer Prev. 2012 Jan;21(1):42-5. doi: 10.1097/CEJ.0b013e32834a7e9b.

PMID:
21849903
17.

Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.

García M, Borràs JM, Milà N, Espinàs JA, Binefa G, Fernández E, Farré A, Pla M, Cardona A, Moreno V.

Prev Med. 2011 Mar-Apr;52(3-4):265-7. doi: 10.1016/j.ypmed.2011.01.012. Epub 2011 Feb 2.

PMID:
21295061
18.

Incontinence and loss of urine due to malformations.

Mila NS.

Urol Int. 1972;27(4):273-4. No abstract available.

Supplemental Content

Support Center